These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 9067292

  • 1. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA.
    Cancer Res; 1997 Mar 15; 57(6):1194-8. PubMed ID: 9067292
    [Abstract] [Full Text] [Related]

  • 2. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C.
    Cancer Res; 2000 Sep 15; 60(18):5111-6. PubMed ID: 11016637
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA.
    Prostate; 2001 Aug 01; 48(3):200-5. PubMed ID: 11494335
    [Abstract] [Full Text] [Related]

  • 4. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 01; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [Abstract] [Full Text] [Related]

  • 5. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C.
    Cancer Epidemiol Biomarkers Prev; 2002 Apr 01; 11(4):337-41. PubMed ID: 11927493
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 01; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [Abstract] [Full Text] [Related]

  • 7. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW.
    Cancer Epidemiol Biomarkers Prev; 1998 May 01; 7(5):379-84. PubMed ID: 9610786
    [Abstract] [Full Text] [Related]

  • 8. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
    Modugno F, Weissfeld JL, Trump DL, Zmuda JM, Shea P, Cauley JA, Ferrell RE.
    Clin Cancer Res; 2001 Oct 01; 7(10):3092-6. PubMed ID: 11595700
    [Abstract] [Full Text] [Related]

  • 9. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B, Koff WJ, Biolchi V, Brenner C, Biolo KD, Spritzer PM, Brum IS.
    Cancer Invest; 2008 Feb 01; 26(1):74-80. PubMed ID: 18181049
    [Abstract] [Full Text] [Related]

  • 10. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 01; 12(2):127-35. PubMed ID: 12582022
    [Abstract] [Full Text] [Related]

  • 11. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang QX, Olsson H.
    Br J Cancer; 1999 Oct 01; 81(4):672-6. PubMed ID: 10574254
    [Abstract] [Full Text] [Related]

  • 12. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.
    Cancer Res; 2002 Feb 15; 62(4):1045-9. PubMed ID: 11861380
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA.
    J Urol; 2000 Aug 15; 164(2):567-72. PubMed ID: 10893645
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
    González A, Javier Dorta F, Rodriguez G, Brito B, Rodríguez MA, Cabrera A, Díaz-Chico JC, Reyes R, Aguirre-Jaime A, Nicolás Díaz-Chico B.
    Eur J Cancer; 2007 Nov 15; 43(16):2373-80. PubMed ID: 17728127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population.
    Correa-Cerro L, Wöhr G, Häussler J, Berthon P, Drelon E, Mangin P, Fournier G, Cussenot O, Kraus P, Just W, Paiss T, Cantú JM, Vogel W.
    Eur J Hum Genet; 1999 Apr 15; 7(3):357-62. PubMed ID: 10234512
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.